Alpha Tau Moves Closer to FDA Clearance for Alpha DaRT
JERUSALEM – May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its pivotal U.S....
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
JERUSALEM – May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its pivotal U.S....
SEOUL, South Korea and ALISO VIEJO, Calif. – May 7, 2026 Medit Corp., a global leader in digital dentistry...
